Headlines Covid-19 Specialties Trending Feeds Videos

Mashup Score: 14

Reuters

Eli Lilly and Co (LLY.N) said it had requested for cancellation of the U.S. authorization granted to its COVID-19 antibody, bamlanivimab, which will now

  • Eli Lilly and Co (LLY.N) said it had requested for cancellation of the U.S. authorization granted to its COVID-19 antibody, bamlanivimab, which will now be used in combination with another to achieve greater efficacy against emerging virus variants.​ https://t.co/BNGtgsjRt0 - view on twitter